GlassScriptPhysician profile
Jay Paul Reddy
NPI 1124373170
$1,510.94
in general payments reported to CMS, 2019-2025
8 companies · $531 in 2025
The $531 reported for 2025 was more than what 76% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2021: $59.98 · 2022: $31.07 · 2023: $178 · 2024: $212 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740 · Travel and Lodging: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.05 |
| Travel and Lodging | $180.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Raysearch Laboratories Ab (Publ) | $485.00 | 2019 | |
| Icotec Medical INC. | $467.82 | 2025 | Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm |
| Astrazeneca Pharmaceuticals LP | $228.61 | 2021-2024 | Enhertu, Lokelma |
| Seagen INC. | $122.09 | 2023 | Padcev |
| Elekta, INC. | $91.96 | 2024 | Elekta Medical Linear Accelerator |
| Elekta Medical Systems Ltda | $63.65 | 2025 | Elekta Medical Linear Accelerator |
| Calliditas Therapeutics US INC. | $37.81 | 2023 | Tarpeyo |
| Olympus America INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Paul Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.